Handling of Analytical Instruments Like HPLC, LCMS, GC, Prep HPLC, SFC, Prep SFC, KF and SOR along with software. Method development by HPLC, GC for RM, Intermediate and final product.
PhD in Biological or Chemical Sciences, Life Sciences with laboratory experience, 0-1 year postdoctoral experience in relevant field with good publication record with at least one research paper in SCI journal.
M.Sc in Human Genctics, Genomics, Proteomics, Biotechnology, Bioinformatics, Biochemistry, Pharmacology, Molecular Biology, Bio-Physics, Space Biology, Data Science, Medicinal Chemistry, Physiology with 2-Year of research experience. Preference will be given to PhD qualified candidates.
M.Sc in Organic Chemistry, Pharmaceutical Chemistry Or M.Pharm, M.S Pharm in Medicinal Chemistry. Minimum one year hands on experience in organic synthesis.
First Class Post Graduate Degree, including the integrated PG Degrees Life Sciences, Nanobiotechnology or Second Class Post Graduate Degree, including the integrated PG Degrees with PhD Life Sciences, Nanobiotechnology.
Post-Graduation in Science M.Pharm, Life Sciences, Biotech, Zoology, Botany etc, with PG Diploma in Clinical Research is Mandatory. Experience Desirable, in handling multicenter projects.
Dual functional COX-2 inhibiting and antimicrobial NSAID-peptidomimetic conjugates as novel therapy to tackle septic infections. Ph.D Chemical sciences or equivalent degree OR three years of research, teaching, design and development after MVSc, M.Pharm, M.E, M.Tech with at least one research paper in Science Citation Index Journal.
Elucidation of Prohibitin as a candidate receptor molecule and development of transgenic cell line for the enhanced growth and replication of Dengue, Chikungunya and Zika. First Class Post Graduate degree in Virology, Medical, Clinical Virology, Medical Microbiology, Microbiology, Biotechnology from a recognized university, institute.
Post Graduate Degree, including the integrated PG degrees in Life Sciences, Pharmacology, Biomedical Engineering with three years post qualification experience or PhD
Switchable tandem CAR-T cells targeting tMUC1 and ROR1 for breast cancer immunotherapy. MSc Life Sciences with at least 60% marks in final exam and 3 years research experience or PhD in life sciences or MBBS with 3 years research experience or MD.